Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Company Profile Marijuana Inc (ID) MAJI

Healthcare Biotechnology Drug Manufacturers - Specialty & Generic
Exousia Pro, Inc., a clinical stage biotechnology company, develops ways to exploit the therapeutic potential of exosomes for the field of oncology in the United States. The company was formerly known as Marijuana, Inc. and changed its name to Exousia Pro, Inc. in April 2025. Exousia Pro, Inc. was incorporated in 2010 and is based in Saint Petersburg, Florida.

Showcase News Releases

Showcase news

Viridian Metals Inc.
Viridian Announces Market Services Agreement With Outside The Box Capital
NU E Power Corp.
NU E Power Corp. Enters Joint Development Agreement for Darkhan Energy Park and Commences Feasibility Studies
Nine Mile Metals Ltd.
Nine Mile Metals Announces Private Placement of up to $1 Million

More Showcase News Releases »